Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis-Reference-Cited by-同舟云学术

Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis

Published:2016-11-29 Issue:2 Volume:141 Page:296-304
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:J. Neurochem.

Author:

Novakova Lenka¹,Axelsson Markus¹,Khademi Mohsen²,Zetterberg Henrik³⁴,Blennow Kaj³,Malmeström Clas¹,Piehl Fredrik²,Olsson Tomas²,Lycke Jan¹

Affiliation:

1. Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy; University of Gothenburg; Gothenburg Sweden

2. Department of Clinical Neuroscience; Karolinska Institutet; Stockholm Sweden

3. Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology at Sahlgrenska Academy; University of Gothenburg; Gothenburg Sweden

4. Department of Molecular Neuroscience; UCL Institute of Neurology; Queen Square London UK

Funder

Swedish Federal Government

Swedish Society of the Neurologically Disabled

Research Foundation of the Multiple Sclerosis Society of Gothenburg

Edit Jacobson Foundation

AFA foundation

Vetenskapsrådet

Knut och Alice Wallenbergs Stiftelse

Torsten Söderbergs Stiftelse

European Research Council

Novartis

Biogen

Genzyme

Teva

IBL International

Eli Lilly and Company

Roche Diagnostics

Sanofi

Astra Zeneca

Hjärnfonden

Amgen

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jnc.13881/fullpdf

Reference38 articles.

1. Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis;Axelsson;J. Neurol.,2011

2. Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis;Axelsson;Mult. Scler.,2014

3. Astrocyte and macrophage regulation of YKL-40 expression and cellular response in neuroinflammation;Bonneh-Barkay;Brain Pathol.,2012

4. YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis;Burman;J. Neuroimmunol.,2016

5. Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis;Comabella;Brain,2010

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An analytical review on the use of artificial intelligence and machine learning in diagnosis, prediction, and risk factor analysis of multiple sclerosis;Multiple Sclerosis and Related Disorders;2024-09

2. The Role of Glial Fibrillary Acidic Protein as a Biomarker in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Meta-Analysis;Medicina;2024-06-26

3. Altered Cerebrospinal Fluid Neurofilament Light Chain but Not Neurogranin Levels Are Associated with Response to Ocrelizumab Treatment in Relapsing-Remitting Multiple Sclerosis: A Preliminary Study;European Neurology;2024-06-18

4. CHIT1 at diagnosis predicts faster disability progression and reflects early microglial activation in multiple sclerosis;Nature Communications;2024-06-12

5. Association of serum glial fibrillary acidic protein with progression independent of relapse activity in multiple sclerosis;Journal of Neurology;2024-04-26